Harvard Medical School11h
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
Harvard Medical School11h
Scientists Identify New Driver of Inflammation Implicated in Autoimmune Diseases
Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...
Harvard Medical School1d
How the Brain Balances Risk and Reward in Making Decisions
The scientists uncovered two groups of brain cells in mice: one that helps mice learn about above-average outcomes and ...
Harvard Medical School13d
Research Pinpoints Weakness in Lung Cancer’s Defenses
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...
Harvard Medical School13d
Surgeons Perform Second Pig Kidney Transplant at Massachusetts General Hospital
A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists has for the second time ...
Harvard Medical School6d
New Imaging Technique Illuminates Bacterial Gene Activity
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
Harvard Medical School2d
Graduation 2024
Congratulations to the HMS/HSDM 2024 graduates! The MD, DMD, master’s, and PhD graduation celebrations and ceremonies were ...
Harvard Medical School15d
Ancient-DNA Study Identifies Originators of Indo-European Language Family
Ancient DNA locates the geographic origin of Proto-Indo-Europeans and Proto-Anatolians and describes their early migrations out of the Caucasus Lower Volga and North Pontic regions of present-day ...
Harvard Medical School7d
Should AI Be Used in End-Of-Life Medical Decisions?
Artificial Intelligence is already being used in clinics to help analyze imaging data, such as X-rays and scans. But the recent arrival of sophisticated large-language AI models on the scene is ...
Harvard Medical School15d
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with advanced kidney cancer, a personalized vaccine generated robust immune response. All patients remained cancer-free for an average of 3 years. The ...